US equities |
NVDA $233.95 ▲+1.34% MU $1,074.89 ▼-2.05% TSLA $370.59 ▲+4.65% SPCX $158.96 ▲+7.35% SNDK $1,719.99 ▼-3.79% AMD $633.91 ▲+2.95% STX $848.99 ▼-10.21% INTC $119.33 ▼-0.56%
FinancialContent

MiMedx Group, Inc - Common Stock (NQ:MDXG)

4.590 -0.050 (-1.08%)
Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about MiMedx Group, Inc - Common Stock

< Previous 1 2 3 4 Next >
News headline image
MiMedx (MDXG) Q2 2026 Earnings Call Transcript ↗
Surgical revenue grew 15% as wound care stabilized ahead of $350M Sanara deal. 
Via The Motley Fool
Topics Earnings
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: MarketAxess Holdings Inc. (Nasdaq – MKTX), CBIZ, Inc. (NYSE – CBZ), Sanara MedTech Inc. (Nasdaq – SMTI), TriCo Bancshares (Nasdaq – TCBK)
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
MiMedx Group Q2 Earnings Call Highlights ↗
MiMedx Group (NASDAQ:MDXG) said it has agreed to acquire Sanara MedTech in a transaction valued at $35 per Sanara share, a deal the company expects to close by the end of 2026. The announcement... 
Via MarketBeat
Topics Earnings
MIMEDX Group (NASDAQ:MDXG) Shares Fall After Q2 Revenue and EPS Slightly Miss Estimates ↗
Via Chartmill
MiMedx Group (NASDAQ:MDXG) Posts Disappointing Q1 Results, Stock Tumbles 8% After-Hours ↗
Via Chartmill
MIMEDX Group Inc (NASDAQ:MDXG) Stock Dips Despite Strong Earnings Beat ↗
Via Chartmill
News headline image
Regenerative Medicine’s Next Chapter: Inside the Race to Make the Body Rebuild Itself
From Biotech Insider
Via GlobeNewswire
News headline image
The Quiet Revolution in Regenerative Medicine: From Replacing Tissue to Rebuilding It
From World Street Intelligence
Via GlobeNewswire
News headline image
A Fresh FDA Catalyst Is Putting Regenerative Wound Care in Focus
Issued on behalf of Conexeu Sciences Inc. 
From Equity Insider
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MiMedx Group, Inc. - MDXG
From Pomerantz LLP
Via GlobeNewswire
News headline image
Earnings Scheduled For October 29, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For July 30, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For April 30, 2025 ↗
 
Via Benzinga
News headline image
A Peek at MiMedx Group's Future Earnings ↗
 
Via Benzinga
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MiMedx Group, Inc. - MDXG
From Pomerantz LLP
Via GlobeNewswire
News headline image
TELA Bio Announces Strategic Board Refreshment with Four Highly Experienced Commerical Leaders to Accelerate Growth and Drive Path to Profitability; The Company Also Reports Preliminary First Quarter 2026 Revenues
From TELA Bio, Inc.
Via GlobeNewswire
What's going on in today's after hours session ↗
Via Chartmill
News headline image
MiMedx (MDXG) Q4 2025 Earnings Call Transcript ↗
MiMedx (MDXG) Q4 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Earnings Scheduled For February 26, 2025 ↗
 
Via Benzinga
News headline image
MDXG Stock Rises As MiMedx Enters Into Exclusive Distribution Agreement For Three Products ↗
According to the agreement, Summit Products Group will distribute Hydrelix, NovaForm, and G4Derm Plus, designed to complement MiMedx’s portfolio of leading surgical and wound products. 
Via Stocktwits
Topics Artificial Intelligence
News headline image
What's going on in today's after hours session ↗
As the regular session of the US market on Monday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment. 
Via Chartmill
News headline image
MiMedx (MDXG) Q3 2025 Earnings Call Transcript ↗
MiMedx (MDXG) Q3 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
MIMEDX GROUP INC (NASDAQ:MDXG) Reports Record Q2 2025 Earnings, Surpassing Estimates and Driving Stock Surge ↗
MIMEDX Group (MDXG) reports record Q2 2025 earnings, beating revenue and EPS estimates with $98.61M in sales and $0.10 EPS. Stock surges 11.8% post-announcement. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
 
Via Benzinga
News headline image
Wednesday's after hours session: top gainers and losers ↗
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements. 
Via Chartmill
News headline image
Simulations Plus, FB Financial And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why Trade Desk Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
 
Via Benzinga
News headline image
Get insights into the top gainers and losers of Monday's after-hours session. ↗
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
< Previous 1 2 3 4 Next >